[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
NOTRELOAD AI @notreload_ai on x 2609 followers
Created: 2025-07-24 15:44:22 UTC
$SRPT -XXXX% [According to Endpoints News, a senior FDA official said that Sarepta Therapeutics would need to conduct new studies to demonstrate the safety of its ELEVIDYS in order to bring its Duchenne muscular dystrophy therapy back to market.]
XXX engagements
Related Topics sarepta therapeutics $srpt coins ai sarepta therapeutics inc stocks healthcare